rxstat › Shortages › Lisdexamfetamine

Lisdexamfetamine (Vyvanse) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 27, 2026

Lisdexamfetamine has no current shortage reported in Canada. It has been in shortage before; the history is below.

A stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).

Products affected
0 / 20
Reports on file
29

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
APO-LISDEXAMFETAMINE CAPSULES
40MG · CAPSULE · APOTEX INC
DIN 02546671 · ended Aug 6, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LISDEXAMFETAMINE CAPSULES
10MG · CAPSULE · APOTEX INC
DIN 02546647 · ended Jul 16, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LISDEXAMFETAMINE CAPSULES
60MG · CAPSULE · APOTEX INC
DIN 02546701 · ended Sep 17, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
60MG · TABLET (CHEWABLE) · TARO PHARMACEUTICALS INC
DIN 02533391 · ended Sep 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LISDEXAMFETAMINE CAPSULES
20MG · CAPSULE · APOTEX INC
DIN 02546655 · ended Aug 6, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
10MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546248 · ended Jun 1, 2026 · Delay in shipping of the drug.
Resolved
PRO-LISDEXAMFETAMINE
10MG · CAPSULE · PRO DOC LIMITEE
DIN 02547031 · ended Mar 24, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
40MG · TABLET (CHEWABLE) · TARO PHARMACEUTICALS INC
DIN 02533375 · ended Sep 25, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
40MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546272 · ended Apr 28, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
60MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546299 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
40MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546272 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ LISDEXAMFETAMINE CAPSULES
50MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02546280 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 29 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Lisdexamfetamine. Health Canada has 29 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Lisdexamfetamine is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).

Recent changes

Common questions

What is Lisdexamfetamine used for?

A stimulant medication used to treat attention deficit hyperactivity disorder (ADHD).

When will Lisdexamfetamine be back in stock in Canada?

Lisdexamfetamine has no active shortage; supply is normal per Health Canada reports.

Why is Lisdexamfetamine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (psychostimulants and nootropics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.